
Eric W. Thomas
Examiner (ID: 13097, Phone: (571)272-1985 , Office: P/2848 )
| Most Active Art Unit | 2848 |
| Art Unit(s) | 2831, 2848, 2835 |
| Total Applications | 2348 |
| Issued Applications | 1918 |
| Pending Applications | 165 |
| Abandoned Applications | 302 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4954880
[patent_doc_number] => 20080187904
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-07
[patent_title] => 'METAL CHELATE-LABELLED PEPETIDES'
[patent_app_type] => utility
[patent_app_number] => 12/026740
[patent_app_country] => US
[patent_app_date] => 2008-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5967
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20080187904.pdf
[firstpage_image] =>[orig_patent_app_number] => 12026740
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/026740 | METAL CHELATE-LABELLED PEPETIDES | Feb 5, 2008 | Abandoned |
Array
(
[id] => 6368111
[patent_doc_number] => 20100074904
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-25
[patent_title] => 'SPECIFIC ACTIVATION OF A REGULATORY T CELL AND ITS USE FOR TREATMENT OF ASTHMA, ALLERGIC DISEASE, AUTOIMMUNE DISEASE, GRAFT REJECTION AND FOR TOLERANCE INDUCTION'
[patent_app_type] => utility
[patent_app_number] => 12/525142
[patent_app_country] => US
[patent_app_date] => 2008-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 17360
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20100074904.pdf
[firstpage_image] =>[orig_patent_app_number] => 12525142
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/525142 | Screening method for the identification of agents capable of activating CD4+CD25+ regulatory T-cells through interactions with the HIV-1 GP120 binding site on CD4 | Jan 29, 2008 | Issued |
Array
(
[id] => 8642083
[patent_doc_number] => 08367061
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-02-05
[patent_title] => 'Anti-idiotype monoclonal antibodies mimicking the HIV gp120 CD4-binding (CD4bs)'
[patent_app_type] => utility
[patent_app_number] => 12/524816
[patent_app_country] => US
[patent_app_date] => 2008-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11280
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12524816
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/524816 | Anti-idiotype monoclonal antibodies mimicking the HIV gp120 CD4-binding (CD4bs) | Jan 28, 2008 | Issued |
Array
(
[id] => 4845505
[patent_doc_number] => 20080181913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-31
[patent_title] => 'Sugar immunogens'
[patent_app_type] => utility
[patent_app_number] => 12/010654
[patent_app_country] => US
[patent_app_date] => 2008-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6104
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20080181913.pdf
[firstpage_image] =>[orig_patent_app_number] => 12010654
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/010654 | Sugar immunogens | Jan 27, 2008 | Abandoned |
Array
(
[id] => 4807482
[patent_doc_number] => 20080171060
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-17
[patent_title] => 'Modulation of immune response and methods based thereon'
[patent_app_type] => utility
[patent_app_number] => 12/011581
[patent_app_country] => US
[patent_app_date] => 2008-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13228
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20080171060.pdf
[firstpage_image] =>[orig_patent_app_number] => 12011581
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/011581 | Modulation of immune response and methods based thereon | Jan 27, 2008 | Abandoned |
Array
(
[id] => 6592501
[patent_doc_number] => 20100048407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-25
[patent_title] => 'METHOD FOR DETECTION OF HUMAN IMMUNODEFICIENCY VIRUS'
[patent_app_type] => utility
[patent_app_number] => 12/522838
[patent_app_country] => US
[patent_app_date] => 2008-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3283
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20100048407.pdf
[firstpage_image] =>[orig_patent_app_number] => 12522838
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/522838 | METHOD FOR DETECTION OF HUMAN IMMUNODEFICIENCY VIRUS | Jan 16, 2008 | Abandoned |
Array
(
[id] => 6637406
[patent_doc_number] => 20100173861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-08
[patent_title] => 'COMBINATIONAL PARADIGM COMBATING HIV, HIV/HSV, OR HIV/HPV INFECTIONS IN HUMANS USING SMALL MOLECULAR WEIGHT COMPOUNDS FROM PLANTS'
[patent_app_type] => utility
[patent_app_number] => 12/523513
[patent_app_country] => US
[patent_app_date] => 2008-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 10094
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20100173861.pdf
[firstpage_image] =>[orig_patent_app_number] => 12523513
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/523513 | Synergistic antiviral compositions comprising a viral attachment inhibitor, integration inhibitor, and proviral transcription inhibitor | Jan 15, 2008 | Issued |
Array
(
[id] => 5992568
[patent_doc_number] => 20110014221
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-20
[patent_title] => 'HIV COMBINATION VACCINE AND PRIME BOOST'
[patent_app_type] => utility
[patent_app_number] => 12/522848
[patent_app_country] => US
[patent_app_date] => 2008-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 16025
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20110014221.pdf
[firstpage_image] =>[orig_patent_app_number] => 12522848
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/522848 | HIV COMBINATION VACCINE AND PRIME BOOST | Jan 10, 2008 | Abandoned |
Array
(
[id] => 6228884
[patent_doc_number] => 20100183622
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-22
[patent_title] => 'VPR FUNCTION AND ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 11/971792
[patent_app_country] => US
[patent_app_date] => 2008-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31677
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20100183622.pdf
[firstpage_image] =>[orig_patent_app_number] => 11971792
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/971792 | VPR FUNCTION AND ACTIVITY | Jan 8, 2008 | Abandoned |
Array
(
[id] => 11859231
[patent_doc_number] => 09738905
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-22
[patent_title] => 'Vector for expressing NC protein of HIV and method for producing NC protein using the same'
[patent_app_type] => utility
[patent_app_number] => 12/520147
[patent_app_country] => US
[patent_app_date] => 2007-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5663
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12520147
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/520147 | Vector for expressing NC protein of HIV and method for producing NC protein using the same | Dec 19, 2007 | Issued |
Array
(
[id] => 8571446
[patent_doc_number] => 08338089
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-25
[patent_title] => 'Method of inhibiting lentiviral infectivity utilizing zinc chelation to inhibit Vif activity'
[patent_app_type] => utility
[patent_app_number] => 11/984672
[patent_app_country] => US
[patent_app_date] => 2007-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 12
[patent_no_of_words] => 10874
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11984672
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/984672 | Method of inhibiting lentiviral infectivity utilizing zinc chelation to inhibit Vif activity | Nov 19, 2007 | Issued |
Array
(
[id] => 6340217
[patent_doc_number] => 20100247570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-30
[patent_title] => 'High Mannose Glycoprotein Epitopes'
[patent_app_type] => utility
[patent_app_number] => 12/514312
[patent_app_country] => US
[patent_app_date] => 2007-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7224
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20100247570.pdf
[firstpage_image] =>[orig_patent_app_number] => 12514312
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/514312 | High Mannose Glycoprotein Epitopes | Nov 12, 2007 | Abandoned |
Array
(
[id] => 4892975
[patent_doc_number] => 20080102073
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-01
[patent_title] => 'Antigen-Antibody Complexes as HIV-1 Vaccines'
[patent_app_type] => utility
[patent_app_number] => 11/929015
[patent_app_country] => US
[patent_app_date] => 2007-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10154
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0102/20080102073.pdf
[firstpage_image] =>[orig_patent_app_number] => 11929015
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/929015 | Antigen-Antibody Complexes as HIV-1 Vaccines | Oct 29, 2007 | Abandoned |
Array
(
[id] => 6080126
[patent_doc_number] => 20110142847
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-16
[patent_title] => 'Methods of Eliciting Broadly Neutralizing Antibodies Targeting HIV-1 GP41'
[patent_app_type] => utility
[patent_app_number] => 11/928612
[patent_app_country] => US
[patent_app_date] => 2007-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 15067
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20110142847.pdf
[firstpage_image] =>[orig_patent_app_number] => 11928612
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/928612 | Methods of Eliciting Broadly Neutralizing Antibodies Targeting HIV-1 GP41 | Oct 29, 2007 | Abandoned |
Array
(
[id] => 5368572
[patent_doc_number] => 20090306131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'CELL LINES WITH LATENT IMMUNODEFICIENCY VIRUS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 11/927262
[patent_app_country] => US
[patent_app_date] => 2007-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 17414
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20090306131.pdf
[firstpage_image] =>[orig_patent_app_number] => 11927262
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/927262 | CELL LINES WITH LATENT IMMUNODEFICIENCY VIRUS AND METHODS OF USE THEREOF | Oct 28, 2007 | Abandoned |
Array
(
[id] => 4765582
[patent_doc_number] => 20080176794
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-24
[patent_title] => 'LONG LASTING FUSION PEPTIDE INHIBITORS OF VIRAL INFECTION'
[patent_app_type] => utility
[patent_app_number] => 11/877300
[patent_app_country] => US
[patent_app_date] => 2007-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30226
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20080176794.pdf
[firstpage_image] =>[orig_patent_app_number] => 11877300
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/877300 | LONG LASTING FUSION PEPTIDE INHIBITORS OF VIRAL INFECTION | Oct 22, 2007 | Abandoned |
Array
(
[id] => 4872749
[patent_doc_number] => 20080199483
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-21
[patent_title] => 'LONG LASTING FUSION PEPTIDE INHIBITORS OF VIRAL INFECTION'
[patent_app_type] => utility
[patent_app_number] => 11/877221
[patent_app_country] => US
[patent_app_date] => 2007-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30221
[patent_no_of_claims] => 90
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0199/20080199483.pdf
[firstpage_image] =>[orig_patent_app_number] => 11877221
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/877221 | LONG LASTING FUSION PEPTIDE INHIBITORS OF VIRAL INFECTION | Oct 22, 2007 | Abandoned |
Array
(
[id] => 4892987
[patent_doc_number] => 20080102085
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-01
[patent_title] => 'VACCINE COMPRISING GP120 AND NEF AND/OR TAT FOR THE IMMUNIZATION AGAINST HIV'
[patent_app_type] => utility
[patent_app_number] => 11/874552
[patent_app_country] => US
[patent_app_date] => 2007-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 18389
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0102/20080102085.pdf
[firstpage_image] =>[orig_patent_app_number] => 11874552
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/874552 | VACCINE COMPRISING GP120 AND NEF AND/OR TAT FOR THE IMMUNIZATION AGAINST HIV | Oct 17, 2007 | Abandoned |
Array
(
[id] => 4517871
[patent_doc_number] => 07939083
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-05-10
[patent_title] => 'Soluble, stabilized, proteolytically cleaved, trimeric HIV-1 gp140 proteins comprising modifications in the N-terminus of the gp41 ectodomain'
[patent_app_type] => utility
[patent_app_number] => 12/312016
[patent_app_country] => US
[patent_app_date] => 2007-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 27
[patent_no_of_words] => 55312
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/939/07939083.pdf
[firstpage_image] =>[orig_patent_app_number] => 12312016
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/312016 | Soluble, stabilized, proteolytically cleaved, trimeric HIV-1 gp140 proteins comprising modifications in the N-terminus of the gp41 ectodomain | Oct 16, 2007 | Issued |
Array
(
[id] => 7739550
[patent_doc_number] => 08105610
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-01-31
[patent_title] => 'Method of making novel erythrovirus V9 VP2 capsid polypeptides'
[patent_app_type] => utility
[patent_app_number] => 11/868380
[patent_app_country] => US
[patent_app_date] => 2007-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 8354
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/105/08105610.pdf
[firstpage_image] =>[orig_patent_app_number] => 11868380
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/868380 | Method of making novel erythrovirus V9 VP2 capsid polypeptides | Oct 4, 2007 | Issued |